within the quickly evolving industry of most cancers therapeutics, comprehension the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is critical for producing efficient remedies. Just about the most promising approaches is using in vitro bystander impact assays, which play a pivotal purpose in maximizing therapeutic efficacy. These assays,